DrugCite
Search

PREVISCAN 20 MG

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Previscan 20 Mg Adverse Events Reported to the FDA Over Time

How are Previscan 20 Mg adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Previscan 20 Mg, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Previscan 20 Mg is flagged as the suspect drug causing the adverse event.

Most Common Previscan 20 Mg Adverse Events Reported to the FDA

What are the most common Previscan 20 Mg adverse events reported to the FDA?

Drug Interaction
23 (7.52%)
International Normalised Ratio Incr...
18 (5.88%)
Anaemia
8 (2.61%)
Confusional State
6 (1.96%)
Malaise
6 (1.96%)
Overdose
6 (1.96%)
Atrial Fibrillation
5 (1.63%)
Renal Failure
5 (1.63%)
Cerebral Haematoma
4 (1.31%)
Fall
4 (1.31%)
Haematoma
4 (1.31%)
Show More Show More
Hypokalaemia
4 (1.31%)
Oedema Peripheral
4 (1.31%)
Renal Failure Acute
4 (1.31%)
Acute Pulmonary Oedema
3 (.98%)
Circulatory Collapse
3 (.98%)
Coma
3 (.98%)
Disorientation
3 (.98%)
Gastrointestinal Haemorrhage
3 (.98%)
Hypertension
3 (.98%)
Vertigo
3 (.98%)
Blood Pressure Decreased
2 (.65%)
Blood Urine Present
2 (.65%)
Brain Death
2 (.65%)
Brain Herniation
2 (.65%)
Cerebral Haemorrhage
2 (.65%)
Dehydration
2 (.65%)
Depressed Level Of Consciousness
2 (.65%)
Erysipelas
2 (.65%)
Erythema
2 (.65%)
Fatigue
2 (.65%)
Haemorrhagic Stroke
2 (.65%)
Helicobacter Infection
2 (.65%)
Inflammation
2 (.65%)
Melaena
2 (.65%)
Meningioma
2 (.65%)
Meningorrhagia
2 (.65%)
Motor Dysfunction
2 (.65%)
Mouth Haemorrhage
2 (.65%)
Myalgia
2 (.65%)
Oxygen Saturation Decreased
2 (.65%)
Prothrombin Level Decreased
2 (.65%)
Pulmonary Embolism
2 (.65%)
Rectal Haemorrhage
2 (.65%)
Shock
2 (.65%)
Somnolence
2 (.65%)
Subdural Haematoma
2 (.65%)
Ulcer Haemorrhage
2 (.65%)
Viral Infection
2 (.65%)
Abdominal Pain Upper
1 (.33%)
Abdominal Wall Haematoma
1 (.33%)
Abnormal Behaviour
1 (.33%)
Acne
1 (.33%)
Acute Leukaemia
1 (.33%)
Aggression
1 (.33%)
Agitation
1 (.33%)
Alanine Aminotransferase Increased
1 (.33%)
Altered State Of Consciousness
1 (.33%)
Amnesia
1 (.33%)
Anaemia Postoperative
1 (.33%)
Angiopathy
1 (.33%)
Anuria
1 (.33%)
Anxiety
1 (.33%)
Aplasia Pure Red Cell
1 (.33%)
Arrhythmia
1 (.33%)
Arthralgia
1 (.33%)
Arthrodesis
1 (.33%)
Aspartate Aminotransferase Increase...
1 (.33%)
Asthenia
1 (.33%)
Atrophy
1 (.33%)
Blindness
1 (.33%)
Blood Creatinine Increased
1 (.33%)
Blood Glucose Increased
1 (.33%)
Blood Pressure Diastolic Increased
1 (.33%)
Blood Pressure Fluctuation
1 (.33%)
Blood Pressure Increased
1 (.33%)
Blood Pressure Systolic Decreased
1 (.33%)
Bronchitis
1 (.33%)
Calcinosis
1 (.33%)
Cardiac Disorder
1 (.33%)
Cardiac Failure
1 (.33%)
Cardiac Tamponade
1 (.33%)
Cardio-respiratory Arrest
1 (.33%)
Cardiomegaly
1 (.33%)
Cataract
1 (.33%)
Cerebral Ischaemia
1 (.33%)
Cerebrovascular Accident
1 (.33%)
Clostridium Difficile Colitis
1 (.33%)
Coagulation Time Prolonged
1 (.33%)
Coagulopathy
1 (.33%)
Cognitive Disorder
1 (.33%)
Colonic Haematoma
1 (.33%)
Creatinine Renal Clearance Decrease...
1 (.33%)
Cyst Rupture
1 (.33%)
Death
1 (.33%)
Dermatitis
1 (.33%)
Disease Recurrence
1 (.33%)
Drug Rash With Eosinophilia And Sys...
1 (.33%)
Dyspnoea
1 (.33%)
Dyspnoea Exertional
1 (.33%)
Eosinophilia
1 (.33%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Previscan 20 Mg, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Previscan 20 Mg is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Previscan 20 Mg

What are the most common Previscan 20 Mg adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Previscan 20 Mg, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Previscan 20 Mg is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Previscan 20 Mg According to Those Reporting Adverse Events

Why are people taking Previscan 20 Mg, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
9
Pulmonary Embolism
8
Atrial Fibrillation
7
Thrombosis Prophylaxis
5
Intracardiac Thrombus
2
Arrhythmia
2
Show More Show More
Embolism Venous
1
Subclavian Vein Thrombosis
1
Arrhythmia Supraventricular
1
Peripheral Vascular Disorder
1
Cerebrovascular Disorder
1
Aortic Valve Replacement
1

Previscan 20 Mg Case Reports

What Previscan 20 Mg safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Previscan 20 Mg. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Previscan 20 Mg.